Creutzfeldt-Jakob Disease

Haemophilia

Volumn 6, Issue SUPPL. 1, 2000, Pages 68-78

  Clement, P ^a  

^a WORLD FEDERATION OF HEMOPHILIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PRION PROTEIN;

ASSAY; BLOOD; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; FAMILIAL DISEASE; HEMOPHILIA; HUMAN; PRIORITY JOURNAL; REVIEW; RISK; SCREENING; SYMPTOM; VIRUS ACTIVATION;

BLOOD COMPONENT TRANSFUSION; CREUTZFELDT-JAKOB SYNDROME; DRUG CONTAMINATION; HEMOPHILIA A; HUMANS; PRIONS;

EID: 0033909576     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00049.x     Document Type: Review

References (48)

1. Harrison's Principles of Internal Medicine. 12th edn. New York: McGraw-Hill, 1991: pp 2037-8.
2. Brown P, Preece M, Will R. 'Friendly fire' in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24-7.
3. Wyngaarden, Smith Bennett. Cecil Textbook of Medicine. 19th edn. W.B. Saunders Co., 1992: pp 2191-3.
4. Gajdusek DC, Gibbs CJ, Alpers M. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1996; 209: 794-6.
5. Pablos-Mendez A, Netto E, Defendini R. Infectious prions or cytotoxic metabolites? Lancet 1993; 341: 159-61.
6. Treichel J. Capturing a scrapie virus. Science News 1981; 5: 359.
7. Prusiner S. The Prion Diseases. Scientific Am 1995; 272: 48-57.
8. Treichel J. Prion: scrapie agent in disguise. Science News 1982; 27: 135.
9. Cohen F, Pan K, Huang Z, Baldwin M, Fletterick R, Prusiner S. Structural clues to prion replication. Science 1994; 264: 530.
10. Kingman S. London meeting explores the ins and outs of prions. Science 1993; 262: 180-1.
11. Pennisi E. Prying into prions. Sci News 1994; 146: 202-3.
12. Tobler I, Gaus SE, Deboer T et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380: 639-42.
13. Sakaguchi S et al. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 1996; 380: 528-31.
14. Collinge J, Palmer MS, Dryden AJ. Genetic pre-disposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-2.
15. Johnson R. Prion disease. The New England J Medicine 1992; 326: 486-7.
16. Bruce ME, Chree A, McConnell I, Foster J, Pearson G, Fraser H. Transmissions to mice indicate that 'new variant' CJD is caused by BSE agent. Nature October 2, 1997; 390: 448.
17. Bruce ME, Will RG, Ironside JW et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498.
18. Bruce ME, McConnell I, Fraser H, Dickinson AG. The disease characteristics of different strains of scrapie in Sine congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol March 1991; 72: 595-603.
19. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new varient' CJD. Nature October 24, 1996; 382: 685-90.
20. Grady D. (Research News) Neurobiology: Ironing out the wrinkles in the prion strain problem. Science 1996; 274: 2010.
21. Dealler S. A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in UK. Transfusion Med 1996; 6: 217-22.
22. Mandell, Douglas Bennett. Principles & Practice of Infectious Diseases. John Wiley & Sons, 1979: pp 1442-5.
23. Gajdusek DC. Unconventional viruses and the origin and disappearance of kuru. Science 1977; 197: 943-60.
24. O'Brien C. Scant data cause widespread concern. Science 1996; 271: 1798.
25. Hill AF, Desburslais M, Joiner S, Sidle K, Gowland I, Collinge LJ. The same prion strain cause vCJD and BSE. Nature October 2, 1997; 390: 498.
26. 'Mad Cow' scare threatens political link between food and agriculture. Nature 1996; 380: 273-4.
27. Fradkin J, Schonberger L, Mills J et al. Creutzfeldt-Jakob Disease in pituitary growth hormone recipients in the United States. JAMA 1991; 265: 880-4.
28. Taylor D, Fraser H, Salacinski P, Dickinson A, Robertson P, Lowey P. Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet 1985; August 3: 260-2.
29. Ridley Baker. Human growth hormone: how big a dose does it take? Gen Virol December 1996; 77: 2895-904.
30. Cooke J. Woman linked to CJD gets aid offer. Sydney Morning Herald September 19, 1997.
31. Kovacs GT, Pepperell R, Evans JH. 'Induction of Ovulation with Human Pituitary Gonadotrophin (HPG). The Aust Experience' Aust NZ J Obstet Gynaecol 1989; 29: 315-81.
32. Kovacs GT, Dennis PM, Shelton RJ et al. Induction of ovulation with human pituitary gonadotrophin Med J Aust. 1984; 140: 575-9.
33. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan January 1979-96 Morbid Morta Weekly Rept (CDC) 1997; 46: 1066-9.
34. Revelle MFDA. Talk Paper. 1994;#T94-55.
35. Manuelidis E, Kim J, Mericangas J, Manuelidis L. Transmission to animals of Creutzfeldt-Jakob Disease from human blood. Lancet 1985; October 19: 896-7.
36. Ricketts MN, Cashman NR, Stratton EE, Eisaadany S. Is Creutzfeldt-Jakob disease transmitted in blood? Emerging Infectious Dis April-June 1997; 3: 155-63.
37. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet March 15, 1997; 349: 99.
38. Tateishi J. Transmission of Creutzfeldt-Jakob Disease from human blood and urine into mice. Lancet November 9.: 1074, 1985.
39. Heye N, Hensen S, Muller N. Creutzfeldt-Jakob Disease and blood transfusion. Lancet 1994; 343: 298-9.
40. Stratton E, Ricketts MN, Gully PR. The epidemiology of Creutzfeldt-Jakob Disease in Canada: a review of mortality data. Emerging Infectious Dis January-March 1997; 3: 63-4.
41. Holman RC, Khan AS, Belay ED, Schonberger LB. Creutzfeld-Jakob Disease in the United States, 1979-1994: Using national mortality data to assess the possible occurrence of variant cases. Emerging Infectious Dis 1996; 2: 333-7.
42. Manuelidis EE, Manuelidis L. Suggested lines between different types of dementias: Creutzfeld-Jakob disease, Alzheimer disease and retroviral CNS infections. Alzheimer Dis Associated Disorders 1989; 3: 100-9.
43. Statement by Kathryn C. Zoon. PhD., Director, Center for Biologies Evaluation and Research, Food and Drug Administration, Department of Health and Human Services before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, US House of Representatives, July 31, 1997.
44. Hsich G, Kennedy K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. The New England J Med September 1996; 335: 924-30.
45. Zerr I, Bodemer M, Otto M et al. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996; 348: 846-9.
46. Korth C et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997; 390: 74-7.
47. Weiss S, Proske D, Neumann M et al. Journal of Virology 1997; 71: 8790-7.
48. Rickles FR. Creutzfeldt-Jakob Disease. Current challenges in the care of hemophilia and von Willebrand disease. Transcripts from the Medical and Scientific Symposium of the Canadian Hemophilia Society Toronto, Canada; May 23, 1997: 18-22.